(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)

C53H71F12N13O15 — CID 164621442

IUPAC(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCN=C(N)N)NCCN1CCN(C(=O)CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C45H67N13O7.4C2HF3O2/c1-30(41(62)54-44(65)36(12-8-19-46)52-31(2)59)51-43(64)35(16-20-50-45(47)48)49-21-24-55-25-27-57(28-26-55)39(60)15-7-9-32-17-22-56(23-18-32)29-40(61)58-37-13-5-3-10-33(37)42(63)53-34-11-4-6-14-38(34)58;4*3-2(4,5)1(6)7/h3-6,10-11,13-14,30,32,35-36,49H,7-9,12,15-29,46H2,1-2H3,(H,51,64)(H,52,59)(H,53,63)(H4,47,48,50)(H,54,62,65);4*(H,6,7)/t30-,35-,36-;;;;/m0..../s1
InChIKeyIXNITWKSBQOFJP-SIDQARSZSA-N
MW1358.20 g/mol
LogP2.49
Rot. Bonds21

About (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)

(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 164621442) has the molecular formula C53H71F12N13O15 and a molecular weight of 1358.20 g/mol. Its IUPAC name is (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID164621442
Molecular FormulaC53H71F12N13O15
Molecular Weight1358.20 g/mol
Exact Mass1357.50
IUPAC Name(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCN=C(N)N)NCCN1CCN(C(=O)CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C45H67N13O7.4C2HF3O2/c1-30(41(62)54-44(65)36(12-8-19-46)52-31(2)59)51-43(64)35(16-20-50-45(47)48)49-21-24-55-25-27-57(28-26-55)39(60)15-7-9-32-17-22-56(23-18-32)29-40(61)58-37-13-5-3-10-33(37)42(63)53-34-11-4-6-14-38(34)58;4*3-2(4,5)1(6)7/h3-6,10-11,13-14,30,32,35-36,49H,7-9,12,15-29,46H2,1-2H3,(H,51,64)(H,52,59)(H,53,63)(H4,47,48,50)(H,54,62,65);4*(H,6,7)/t30-,35-,36-;;;;/m0..../s1
InChIKeyIXNITWKSBQOFJP-SIDQARSZSA-N
XLogP2.49
TPSA432.22 Ų
H-Bond Donors12
H-Bond Acceptors16
Rotatable Bonds21
Heavy Atoms93
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001358.20
LogP ≤ 52.49
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) (CID 164621442) is (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) is CC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCN=C(N)N)NCCN1CCN(C(=O)CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is IXNITWKSBQOFJP-SIDQARSZSA-N. The full InChI is InChI=1S/C45H67N13O7.4C2HF3O2/c1-30(41(62)54-44(65)36(12-8-19-46)52-31(2)59)51-43(64)35(16-20-50-45(47)48)49-21-24-55-25-27-57(28-26-55)39(60)15-7-9-32-17-22-56(23-18-32)29-40(61)58-37-13-5-3-10-33(37)42(63)53-34-11-4-6-14-38(34)58;4*3-2(4,5)1(6)7/h3-6,10-11,13-14,30,32,35-36,49H,7-9,12,15-29,46H2,1-2H3,(H,51,64)(H,52,59)(H,53,63)(H4,47,48,50)(H,54,62,65);4*(H,6,7)/t30-,35-,36-;;;;/m0..../s1.
What are the key properties of (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid)?
(2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 1358.20 g/mol, XLogP of 2.49, 21 rotatable bonds, 12 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-acetamido-5-amino-N-[(2S)-2-[[(2S)-4-(diaminomethylideneamino)-2-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butanoyl]piperazin-1-yl]ethylamino]butanoyl]amino]propanoyl]pentanamide;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 164621442), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).